Therapeutic Changes in HER2+ Breast Cancer

home / publications / supplements / 2020-updates-in-her2-breast cancer
Novel Treatments in HER2-Positive Breast Cancer

Novel Treatments in HER2-Positive Breast Cancer

May 18th 2020
Video

OncLive interviewed experts on novel treatments in HER2-positive breast cancer. 

Dr. Thompson on Sequencing Strategies in HER2+ Breast Cancer

Dr. Thompson on Sequencing Strategies in HER2+ Breast Cancer

Forrest Thompson, MD
March 20th 2020
Video

Forrest Thompson, MD, discusses sequencing strategies in HER2-positive breast cancer.

Dr. Hurvitz on Treatment Options in Early-Stage HER2+ Breast Cancer

Dr. Hurvitz on Treatment Options in Early-Stage HER2+ Breast Cancer

Sara A. Hurvitz, MD
March 19th 2020
Video

Sara A. Hurvitz, MD, discusses available treatment options in early-stage HER2-positive breast cancer.

Dr. Olajide on Managing Risk of Interstitial Lung Disease With Trastuzumab Deruxtecan in Breast Cancer

Dr. Olajide on Managing Risk of Interstitial Lung Disease With Trastuzumab Deruxtecan in Breast Cancer

Oludamilola (Lola) A. Olajide, MD
March 19th 2020
Video

Oludamilola (Lola) A. Olajide, MD, discusses managing the risk of interstitial lung disease with fam-trastuzumab deruxtecan-nxki in breast cancer.

Site Logo

Dr. Krill-Jackson on the Potential Utility of Trastuzumab Deruxtecan in Metastatic Breast Cancer

Elisa Krill-Jackson, MD
March 12th 2020
Video

Elisa Krill-Jackson, MD, discusses the potential future utility of fam-trastuzumab deruxtecan-nxki in the treatment of patients with metastatic breast cancer.

Dr. Hurvitz on Additional Research Needed With Trastuzumab Deruxtecan in HER2+ Breast Cancer

Dr. Hurvitz on Additional Research Needed With Trastuzumab Deruxtecan in HER2+ Breast Cancer

Sara A. Hurvitz, MD
March 11th 2020
Video

Sara A. Hurvitz, MD, discusses the need for additional research with fam-trastuzumab deruxtecan-nxki in HER2-positive breast cancer.